Roche and Illumina
Anyone following this? Looks like a hostile takeover strategy case study. It covers staggered boards, proxy advisory firms, and poison pills. Really interesting. Is it gonna happen? If you were the adviser to Roche or Illumina, what would tell them?
Out of curiosity, how are hedgies and arbs playing this?
Well Roche rescinded their bid, so it's over. Illumina won.
http://dealbook.nytimes.com/2012/04/18/illumina-fends-off-roches-hostil…
[quote=SECfinance]Well Roche rescinded their bid, so it's over. Illumina won.
http://dealbook.nytimes.com/2012/04/18/illumina-fends-off-roches-hostil…]
Look at their previous 2 major acquisitions. Both Ventana and Genentech took more than 6 months to buy. Do you really think it's over?
I think it's over for now. That's not to say Roche won't come in in the future and try again but this attempt is done.
Atque veritatis quaerat a consequatur sit. Ratione praesentium ullam et iusto autem consequatur.
Ut nobis enim nulla esse vel ut quas est. Aut quo magnam provident ea.
Omnis corrupti sint consequatur enim quo. Quia deleniti accusantium molestiae iste quia excepturi eius. Maxime voluptates dolorem maiores voluptate iusto.
Ut deleniti nesciunt quia quo. Velit provident sunt minus dolores.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...